Material
TestBank:
s
Advanced PharmacologyforPrescribers 1stEdition Luu KayingoLatest Edi
ss s j s j j s
tion,2024
ss s
, Stuvia.com ss- ssThe ssMarketplace ssto ssBuy ssand ssSell ssyour ssStudy
Material
Table ofContents j
Chapterj 1: An Introductionj to Evidence-Based Clinicalj PracticeGuidelines ............................................... 3
ss ss ss ss ss ss ss s
Chapterj2:Pharmacokinetics /Chapter3: Pharmacodynamics ....................................................................... 13
s ss s
Chapter4: Pharmacogeneticsj and Pharmacogenomics................................................................................ 25
ss ss ss
Chapter 5: Pharmacology Across thejLife Span ............................................................................................. 30
s s ss ss ss
Chapter 6: Drug-Therapy Prescribingjin Special Populations ...................................................................... 36
ss ss ss ss ss
Chapter 7: DrugDevelopmentj and Approval ................................................................................................ 45
s s s ss ss
Chapter 8-Chapter 10: Foundations of Prescription WritingjChapter 9: ResponsibleControlled-
ss ss ss ss s s ss ss ss
s Substance Prescribing Chapter 10:Antibiotic Stewardship ..................................................................... 51
s ss ss ss ss
Chapter 11: Applied Calculationsjfor Prescribing ......................................................................................... 58
ss s ss ss
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
ss ss ss ss ss ss ss ss ss
Focused PrescribingjChapter 13: Pharmacotherapyfor Ear, Nose, Mouth, andThroat Conditions/Chapter
ss ss ss ss ss s s ss
14: Pharmacotherapyfor EyejConditions .................................................................................................... 67
ss ss ss
Chapter 15: Pharmacotherapy for Skin Conditions ...................................................................................... 74
ss ss ss ss ss
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................... 81
ss ss ss ss ss
Chapterj 17: Pharmacotherapyfor Cardiovascular Conditions ..................................................................... 94
ss ss ss ss
Chapterj 18: Pharmacotherapyforj Respiratory Conditions ........................................................................ 106
ss ss ss ss
Chapter 19: PharmacotherapyforGastrointestinal Conditionsand Conditions RequiringNutritional Support
ss ss ss ss ss ss
................................................................................................................................................................... 117
Chapterj 20: PharmacotherapyforjGenitourinary Conditions ...................................................................... 128
ss s s ss
Chapter 21: Pharmacotherapyfor Renal, Acid–Base, Fluid,and ElectrolytejDisorders ................................ 133
s s ss ss ss s ss
Chapter 22: Pharmacotherapyfor Musculoskeletal and Rheumatologic Conditions ................................... 146
ss s ss s ss ss
Chapter 23: Therapeutic Applicationsjof Immunology and Vaccines.......................................................... 158
s s ss ss ss ss
Chapter 24: Pharmacotherapyfor Endocrine Disorders ............................................................................... 163
ss s s ss ss
Chapterj25: Pharmacotherapyfor Hematologic Disorders........................................................................... 174
s s ss ss
Chapterj26: Hematology/Oncologyand Supportive Careforj the Nononcologist ....................................... 190
ss ss ss ss ss
Chapter 27: Pharmacotherapy Relatedj to Women’s Health Conditions .................................................... 196
ss ss ss ss ss ss ss
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .......................................................... 211
ss ss ss ss ss ss ss
Chapter 29: Pharmacotherapy Relatedj to Transgender Care ..................................................................... 217
ss ss ss ss ss ss
Chapter 30: Antimicrobial Pharmacotherapy .............................................................................................. 224
ss s ss
Chapter 31: Antiretroviral Pharmacotherapy .............................................................................................. 235
ss ss ss
Chapter 32: PsychopharmacologyandIntegrative Health: Combined Treatment ofPsychiatricjandNeurocogn
ss s s ss s ss s s
itiveConditions ......................................................................................................................................... 247
ss s
Chapter 33: Pharmacotherapyfor Pain Management ................................................................................. 257
ss s ss ss
Chapterj34: Substance Use Disorderj III: Health Promotion and Maintenance ........................................... 267
ss ss ss ss ss ss ss ss
Chapterj35:Over-the-CounterjMedications................................................................................................. 283
Chapterj36: Pharmacotherapy forjObesity .................................................................................................. 291
ss ss
, Stuvia.com ss- ssThe ssMarketplace ssto ssBuy ssand ssSell ssyour ssStudy
Material
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
ss ss ss s s ss ss ss ss
MULTIPLE CHOICE s
• What is the primary purpose of the nursing assessment?
ss ss ss ss ss ss ss ss
A. Identifyingj underlyingj pathologic ss ss s s conditions
B. Assisting thej physician in identifying medical conditions ss ss s s ss ss ss
C. Determining the patients mental status ss ss ss ss
D. Exploring patientj responses to health problems ss ss ss ss ss
ANS:jD
A nursingassessment is done to identify thejpatients response to health
ss ss ss ss ss ss ss ss ss
proble
ss ms. Duringthe nursingjassessment
ss phase, a ss ss ss ss
comprehensiveinformation base i s developed through ajphysical
ss ss ss ss ss ss ss
examination,
ss nursingjhistory, medication histo ry, and ss ss ss ss ss
professionaljobservation. Identifyingunderlyingpathologic condition
ss s ss ss s s
and assistingjthe physician in identifyingmedical conditions is notjpart of
ss ss ss ss ss ss ss ss ss
thej nursingjprocess. Determiningjthe patients mental status is one partj
ss s s ss ss s s ss s s s s ss
of the nurs ing assessment, but it is notjthe primary purpose.
ss ss ss ss ss ss s s s s s s ss ss
DIF: Cognitive Level: Comprehension
ss ss ss
REF: dm 36 OBJ: 1 | 3 TOP: NursingjPro
ss ss ss ss ss ss ss ss ss
cess Step: Assessment
ss ss ss
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
ss ss ss ss ss ss ss ss
• Whatjis the basis of the NANDAI taxonomy?
ss ss ss ss ss ss
A. Functional health patterns ss ss
B. Human response patterns ss s s
C. Basic human needs ss ss
D. Pathophysiologic needs ss
ANS:jB
The NANDA I taxonomy identifiesj human response patterns. Functional
ss ss ss ss ss ss ss ss
components of health patterns are limited to activity, fluidvolume,
ss ss ss ss ss ss ss ss ss
nutrition, self care, and sensory perception. Basic human needs comprise
ss ss ss ss ss ss ss ss ss ss
less than mer ely health patterns. Pathophysiologic needs are notpart of
ss ss ss ss ss ss ss ss ss s s ss
the scopejof NAN DAI.
ss ss ss ss
, Stuvia.com ss- ssThe ssMarketplace ssto ssBuy ssand ssSell ssyour ssStudy
Material
DIF: Cognitive Level: Knowledge REF:
ss ss ss ss
pp. 37-38 OBJ: 5 TOP:
ss ss ss ss
NursingjProcess Step: Diagnosis ss ss
MSC: NCLEX Client Needs Category: Physiological Integrity
ss ss ss ss ss ss
• Which task is included in the assessment step of the nursing process?
ss ss ss ss ss ss ss ss ss ss ss
A. Establishing patient goals/outcomes ss s s
B. Implementingj the nursingj care plan (NCP) ss ss ss ss ss
C. Measuringj goal/outcome achievement ss ss
D. Collectingjand communicatingj data s s ss
ANS: D ss
Data are collected and communicated in the assessment phase of the
ss ss ss ss ss ss ss ss ss ss
nursingp rocess. Establishingjgoals is thejfunction of planning.
ss ss ss ss ss ss ss
Implementingthe NCP is the function of implementation. ss ss ss ss ss ss
Measuringjoutcom e achievement is the function of evaluation.
ss s s ss ss ss ss ss ss
DIF: Cognitive Level: Comprehension
ss ss ss
REF: dm 36 OBJ: 2 | 3 TOP: Nursing Pro
ss ss ss ss ss ss ss ss ss s
cess Step: Assessment
ss ss ss
MSC: NCLEXj Clientj Needs Category: Health Promotion and Maintenance
ss ss ss ss ss ss ss ss
• Which statement regardingj nursing diagnoses is accurate?
ss ss ss ss ss s s
a. Nursingdiagnoses remain the same for as longjas the disease is present. ss ss ss ss ss ss ss ss ss s s
b. Nursing diagnoses are written to identify disease states. ss ss ss ss ss ss ss
c. Nursing diagnoses describe patient problems that nurses ss ss ss ss ss ss s s treat.
d. Nursing diagnoses identify causes related to illness. ss ss ss ss ss ss
ANS:jC
Diagnostic statements identify problemsja nurse is independently able to
ss ss ss ss ss ss ss ss
treat within the scope of professional practice. Nursingjdiagnoses vary
ss ss ss ss ss ss ss ss ss
with the ch angingjcondition of the patient. The responsepatterns
ss ss ss ss ss ss ss ss ss
arejunique to the patien t and are notjdisease specific. Nursingdiagnoses
ss ss ss ss s s ss ss ss ss ss
describethe patients humanjr esponse pattern.
ss ss ss ss ss
DIF: Cognitive Level: Comprehension
ss ss ss